Zhejiang Taimei Medical Technology Past Earnings Performance
Past criteria checks 0/6
Zhejiang Taimei Medical Technology has been growing earnings at an average annual rate of 5.5%, while the Healthcare Services industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 3.8% per year.
Key information
5.5%
Earnings growth rate
17.1%
EPS growth rate
Healthcare Services Industry Growth | 22.3% |
Revenue growth rate | 3.8% |
Return on equity | -36.0% |
Net Margin | -62.3% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Zhejiang Taimei Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 576 | -359 | 493 | 144 |
31 Dec 23 | 573 | -347 | 427 | 169 |
31 Dec 22 | 549 | -413 | 478 | 208 |
31 Dec 21 | 466 | -480 | 450 | 191 |
31 Dec 20 | 303 | -524 | 518 | 109 |
31 Dec 19 | 187 | -389 | 403 | 84 |
31 Dec 18 | 60 | -183 | 146 | 41 |
Quality Earnings: 2576 is currently unprofitable.
Growing Profit Margin: 2576 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2576 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.5% per year.
Accelerating Growth: Unable to compare 2576's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2576 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.9%).
Return on Equity
High ROE: 2576 has a negative Return on Equity (-36.01%), as it is currently unprofitable.